aPL antibodies have been shown to be associated with clinical events such as arterial and venous thrombosis and pregnancy complications in patients with antiphospholipid syndrome (APS) or SLE-associated APS (SLE/APS) [12,13,14,15,16]. Here, FASLG is linked to systemic lupus erythematosus.